Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pharmacogenomics J. 2016 Mar 15;17(4):351–359. doi: 10.1038/tpj.2016.18

Fig. 5. Survival analysis of Sulfasalazine, Fluoxetine, Clozapine, and Betulinic Acid DRS profiles.

Fig. 5

(A) Sulfasalazine, (B) Fluoxetine, (C) Clozapine, (D) and Betulinic Acid were identified as drugs associated with AML patient survival and chosen for further experimental validation. DRS profiles of all drugs were associated with AML patient survival with P<0.05 (Logrank test).